Stockscreener 앱 받기
1.37
0.00%
0.00
Enveric Biosciences Inc 주식(ENVB)의 최신 뉴스
ARMISTICE CAPITAL, LLC Acquires Stake in Enveric Biosciences Inc (ENVB) - GuruFocus
Enveric (ENVB) Snapshot: Slides 0.74% to $1.34 in the Latest Reading; Technical View: Support at $1.27 and Resistance at $1.41 Frame the Range in Latest TradingFundamental Weighted - vinanet.vn
Enveric (ENVB) Daily Review: Moves 8.78% Lower to $1.35 for the Current Session; Price-Level Context: the Supplied Trading Band Runs From $1.28 to $1.42 in Latest TradingVanna Flow - vinanet.vn
Enveric Biosciences (ENVB) Q2 Results Highlight Challenges Amid Low Valuation Signals - GuruFocus
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - BioSpace
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits
Form 8K Enveric Biosciences Inc For: 14 August By Investing.com - Investing.com Nigeria
Enveric Biosciences reports $3.0M net loss, $8.3M cash on hand for Q2 2026 - TradingView
Enveric Biosciences (ENVB) posts H1 2026 loss but raises $8.3M cash - Stock Titan
Enveric Biosciences Posts $3.0 Million Second-Quarter Net Loss - Quiver Quantitative
Enveric Biosciences (NASDAQ: ENVB) deepens Q2 loss while pushing EB-003 toward trials - Stock Titan
Enveric Biosciences (ENVB) holders Lind entities report 1.3–1.4% warrant-based stake - Stock Titan
Armistice Capital (ENVB) discloses 405,092-share position in Enveric Biosciences - Stock Titan
Enveric Biosciences (ENVB) investors disclose 2.93% stake via 111,145-share warrants - Stock Titan
FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High - microdose.buzz
ENVB Q4 2024 Earnings: Per-Share Loss of -57.6 Overshoots Consensus by 1,946%Management Guidance Update - Vinanet
Enveric Biosciences Inc (NASDAQ: ENVB) Share Price, ENVB Stock News, ENVB Share Price & Updates - Kalkine
Enveric Biosciences Says New Preclinical Data Confirms Non-Hallucinogenic Profile For Lead Psychiatric Ca - Benzinga
Enveric reports preclinical data on EB-003 drug candidate By Investing.com - Investing.com Canada
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Yahoo! Finance Canada
Enveric Biosciences (ENVB) Rallies 8.4% to $1.57 — Key Levels to WatchStock Analysis - dars.gov.et
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network
Enveric Biosciences Inc (ENVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.137|Chg%:-0.203 - TradingKey
TradingKey - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.290|Chg%:-0.030 - TradingKey
Enveric Biosciences Inc (ENVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enveric Biosciences (ENVB) Slides to $1.29, Testing Key Support at $1.23Positive Gamma - vinanet.vn
Enveric Biosciences Inc (ENVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enveric Biosciences Shares Edge Lower as Support Level ApproachesBeta Neutral Pair - dars.gov.et
ENVB Q4 2024 Earnings: Massive EPS Miss Highlights Pre-Revenue Biotech ChallengesEstimate Revision Count - vinanet.vn
Enveric Biosciences (ENVB) Retreats 4.5% as Selling Pressure Intensifies Near Key SupportGrowth Stock Picks - dars.gov.et
ENVB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
Enveric Biosciences Inc (ENVB:UW): Stock Price, Quote and News - BNN Bloomberg
Price to sales forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to sales forward of Enveric Biosciences, Inc. – BOATS:ENVB - TradingView
MSN Money - MSN
Enterprise value to EBITDA forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to book forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Enveric Biosciences (ENVB) Slips 5.6%: Testing Key Support as Biotech Sentiment WanesJelly Roll Trade - dars.gov.et
Enveric Biosciences (ENVB) Rebounds Slightly, Testing Key Resistance Near $1.50Earnings Miss Risk - dars.gov.et
Enterprise value to EBIT forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to earnings forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
ENVB Q4 2024 Earnings: Significant Earnings Miss Amid Pre-Revenue StageEarnings Manipulation Risk - dars.gov.et
ENVB Q4 2024 Earnings: Significant EPS Miss Highlights Ongoing R&D Investment Amid Pre-Revenue StageEarnings Quality Score - dars.gov.et
Enveric Biosciences to Participate in B. Riley's Mind, Muscle & Vision Summit - GuruFocus
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
ENVBEnveric Biosciences Inc Earnings - Finviz
Enveric Biosciences Company Profile & Introduction - Moomoo
Enveric Biosciences, Inc. Actuals & Estimates (NASDAQ:ENVB) - TradingView
Enveric Biosciences Inc (ENVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enveric Biosciences Inc (ENVB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ENVERIC BIOSCIENCES INC (ENVB) Stock Chart - ChartMill
8.37%
0.23%
자본화:
|
볼륨(24시간):